Name Betaxolol
Classes Cardiovascular Agent
Ophthalmic Preparation
Antihypertensive
Beta-Adrenoceptor Blocker
Glaucoma Agent
Diseases Glaucoma
Ophthalmic Disease

Betaxolol

Betaxolol is a selective (beta-1-adrenergic) receptor blocker with no membrane stabilizing (local anesthetic) activity and no intrinsic sympathomimetic action.

Betaxolol is indicated for the following conditions-

  • Intraoccular hypertension
  • Glaucoma
  • Betaxolol is available as ophthalmic drops.
  • 0.5 percent ophthalmic solution: 1 drop of Betaxolol Hydrochloride ophthalmic solution twice daily in the afflicted eye(s). It may take a few weeks for the intraocular pressure-lowering response to settle in some patients.
  • 0.25 percent ophthalmic solution: One to two drops of Betaxolol Hydrochloride ophthalmic solution in the afflicted eye(s) twice daily is the suggested dose.

How to administer eye drops:

Side effects associated with the use of betaxolol are-

  • headache
  • ocular discomfort
  • vision blurred
  • lacrimation increased
  • bradycardia
  • keratitis

 

  • The immediate treatment goal in individuals with angle-closure glaucoma is to reopen the angle via constriction of the pupil using a miotic drug. Because Betaxolol has little effect on the pupil, it should be used with a miotic to lower excessive intraocular pressure in angle-closure glaucoma. 
  • In individuals with spontaneous hypoglycemia or diabetic patients, beta-adrenergic blocking medications should be used with caution since they can conceal the signs and symptoms of acute hypoglycemia.

Contraindication

Hypersensitivity to any component of this product or any drug of the beta blocker class, such as-

Betaxolol should not be used in patients with-

  • sinus bradycardia
  • atrioventricular block greater than first degree
  • cardiogenic shock
  • patients with a history of overt cardiac failure.